Anthony DeStefano
Consultant and former senior vice president of the United States Pharmacopeia's General Chapters and Healthcare Quality Standards
Dr Anthony DeStefano Tony began his career at Procter & Gamble in mass spectrometry. By 2008 he was the senior vice president of the General Chapters and Healthcare Quality Standards at the United States Pharmacopeia. During that time, he oversaw the development of general chapters 232 and 233 and was the USP observer to the ICH Q3D Expert Working Group. He current consults on analytical, bioanalytical, and compendial science issues.
Latest content from Anthony DeStefano
Understanding Sources of Heavy Metals in Cannabis and Hemp: Benefits of a Risk Assessment Strategy – Part 4
In the fourth and final part of their new series, Rob Thomas and Tony Destefano explore potential elemental sources in the production, packaging, and delivery of cannabis consumer products.
VIEW
Understanding Sources of Heavy Metals in Cannabis and Hemp: Benefits of a Risk Assessment Strategy – Part 3
In the third part of their new series, Rob Thomas and Tony Destefano examine the critically important step of extracting cannabinoids from the biomass, the flower, and other parts of the cannabis plant.
VIEW
Understanding Sources of Heavy Metals in Cannabis and Hemp: Benefits of a Risk Assessment Strategy – Part 2
In the second part of a new series, Rob Thomas and Tony Destefano discuss whether a risk assessment strategy could help industry members to better understand all the potential sources of elemental contaminants along the cannabis supply chain.
VIEW
Understanding Sources of Heavy Metals in Cannabis and Hemp: Benefits of a Risk Assessment Strategy – Part 1
In the first part of a new series, Rob Thomas and Tony Destefano outline what the cannabis testing sector can learn from the pharmaceutical industry when it comes to heavy metal contamination.
VIEW